文传商讯
Boehringer Ingelheim announces European Medicines Agency’s filing acceptance and validation of mark
2021-10-30 00:29:08
PMI to Commit Additional USD 200 Million to Corporate Venture Capital Activities of PM Equity Partne
2021-10-30 00:29:08
Boehringer Ingelheim and King’s College London Join Forces to Progress New Therapeutic Concepts in
2021-10-30 00:29:08
Philip Morris International Creates New Management Positions to Drive Multicategory Leadership and A
2021-10-30 00:29:08
Vifor Pharma and Angion report topline results from phase-III registration trial of ANG-3777 in kidn
2021-10-30 00:29:08
















